Qianzhi Group Holding (Cayman) Limited, the holding company of Shenzhen Qianzhi Biotechnology Co., Ltd., Shenzhen Qianzhi Biotechnology Co., Ltd. from Shenzhen, Guangdong, signed a merger agreement with SPAC (US special purpose acquisition company) Bowen Acquisition Corp (BOWN) to be listed on the US NASDAQ through a backshell SPAC.

The deal has been approved by both boards of directors and is expected to close in the second or third quarter of 2024.

According to reports, Qianzhi Biotechnology, headquartered in Shenzhen, Guangdong, is a biotechnology company focusing on health and wellness. It is also an early adopter and developer of plant-based and ozone products for antibacterial, skincare, gynecological, and andrological applications. Most of Qianzhi Biotech's products are ozonized, oil-based products, and infused with herbal ingredients in formulations. Other proprietary products of Qianzhi Biotech include ozone disinfectant products produced using room temperature ozone curing technology. Qianzhi Biotech believes that compared with traditional alcohol, chlorine or phenol disinfectants, its ozone disinfectants are safer, more environmentally friendly, and more efficient.